Robert Lawatscheck - Publications

Finerenone in Type 1 Diabetes and Chronic Kidney Disease. Reply.

Journal: The New England journal of medicine

Published: June 03, 2026

Efficacy and safety of finerenone in patients with chronic kidney disease: an individual participant data pooled analysis (INFINITY).

Journal: Lancet (London, England)

Published: April 23, 2026

Effect of Finerenone on Albuminuria in Type 1 Diabetes by Baseline HbA1c Level and Diabetes Duration: An Exploratory Analysis of the FINE-ONE Trial.

Journal: Diabetes care

Published: April 14, 2026

Finerenone in Type 1 Diabetes and Chronic Kidney Disease.

Journal: The New England journal of medicine

Published: March 04, 2026

Comparing CKD populations with T1D and T2D: a perspective based on the FINE-ONE and FIDELITY populations.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: May 23, 2025

Hypokalaemia in patients with type 2 diabetes and chronic kidney disease: the effect of finerenone-a FIDELITY analysis.

Journal: European heart journal. Cardiovascular pharmacotherapy

Published: April 10, 2024

Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by diuretic use: A FIDELITY analysis.

Journal: European journal of heart failure

Published: February 23, 2024

Prevalence of Chronic Kidney Disease in Type 1 Diabetes Among Adults in the U.S.

Journal: Diabetes care

Published: February 16, 2024

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis.

Journal: Annals of internal medicine

Published: December 04, 2023

Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials.

Journal: Kidney medicine

Published: December 04, 2023

Finerenone in Hispanic Patients With CKD and Type 2 Diabetes: A Post Hoc FIDELITY Analysis.

Journal: Kidney medicine

Published: September 25, 2023

Validation of the Klinrisk chronic kidney disease progression model in the FIDELITY population.

Journal: Clinical kidney journal

Published: September 14, 2023